Abstract |
Folate-based small molecule drug conjugates (SMDCs) are currently under development and have shown promising preclinical and clinical results against various cancers and polycystic kidney disease. Two requisites for response to a folate-based SMDC are (i) folate receptor alpha (FRα) protein is expressed in the diseased tissues, and (ii) FRα in those tissues is accessible and functionally competent to bind systemically administered SMDCs. Here we report on the development of a small molecule reporter conjugate (SMRC), called EC2220, which is composed of a folate ligand for FRα binding, a multilysine containing linker that can cross-link to FRα in the presence of formaldehyde fixation, and a small hapten ( fluorescein) used for immunohistochemical detection. Data show that EC2220 produces a far greater IHC signal in FRα-positive tissues over that produced with EC17, a folate- fluorescein SMRC that is released from the formaldehyde-denatured FRα protein. Furthermore, the extent of the EC2220 IHC signal was proportional to the level of FRα expression. This EC2220-based assay was qualified both in vitro and in vivo using normal tissue, cancer tissue, and polycystic kidneys. Overall, EC2220 is a sensitive and effective reagent for evaluating functional and accessible receptor expression in vitro and in vivo.
|
Authors | Haiyan Chu, Jonathan M Shillingford, Joseph A Reddy, Elaine Westrick, Melissa Nelson, Emilia Z Wang, Nikki Parker, Albert E Felten, Jeremy F Vaughn, Le-Cun Xu, Yingjuan J Lu, Iontcho R Vlahov, Christopher P Leamon |
Journal | Molecular pharmaceutics
(Mol Pharm)
Vol. 16
Issue 9
Pg. 3985-3995
(09 03 2019)
ISSN: 1543-8392 [Electronic] United States |
PMID | 31356752
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- FOLR1 protein, human
- Folate Receptor 1
- N(alpha)-9-fluorenylmethoxycarbonyl-N(epsilon)-4-methyltrityllysine
- Oligopeptides
- Trityl Compounds
- Folic Acid
- protein kinase D
- Protein Kinase C
- Fluorescein-5-isothiocyanate
- Lysine
- Doxycycline
|
Topics |
- A549 Cells
- Animals
- Doxycycline
(pharmacology)
- Fluorescein-5-isothiocyanate
(chemistry, metabolism)
- Folate Receptor 1
(analysis, metabolism)
- Folic Acid
(analogs & derivatives, chemistry, metabolism)
- HeLa Cells
- Humans
- Lysine
(analogs & derivatives, chemistry, metabolism)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mice, Transgenic
- Molecular Targeted Therapy
(methods)
- Neoplasms
(drug therapy, metabolism)
- Oligopeptides
(chemistry, metabolism)
- Polycystic Kidney Diseases
(chemically induced, drug therapy, metabolism)
- Protein Kinase C
(genetics)
- Tissue Distribution
- Trityl Compounds
(chemistry, metabolism)
- Xenograft Model Antitumor Assays
|